{"id":11655,"date":"2026-10-28T13:48:56","date_gmt":"2026-10-28T10:48:56","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?ism_drug=flecainide-flekainid"},"modified":"2026-10-28T13:48:57","modified_gmt":"2026-10-28T10:48:57","slug":"flecainide-flekainid","status":"publish","type":"ism_drug","link":"https:\/\/www.ortaakarsu.net\/?ism_drug=flecainide-flekainid","title":{"rendered":"Flecainide (Flekainid)"},"content":{"rendered":"<p><strong>Flecainide (Flekainid)<\/strong>, Flekainid etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi sayfas\u0131d\u0131r.<\/p>\n<p><strong>Uygulama kapsam\u0131:<\/strong> A\u011f\u0131zdan. Ba\u015flama, doz veya form\u00fclasyon de\u011fi\u015fikli\u011fi ve b\u0131rakma karar\u0131 uzman g\u00f6zetiminde EKG ve gerekti\u011finde kan ila\u00e7 d\u00fczeyi izlemiyle verilir. Farkl\u0131 g\u00fc\u00e7 ve farmas\u00f6tik formlar\u0131n birbirinin yerine kullan\u0131labilece\u011fi varsay\u0131lmamal\u0131d\u0131r.<\/p>\n<h2>T\u00fcrkiye\u2019de yurt d\u0131\u015f\u0131ndan temin kayd\u0131<\/h2>\n<p><a href=\"https:\/\/www.teb.org.tr\/docs\/3aac322e-7bec-4df1-a37f-0dd1757bed11\/yurtdisi-aktif-ilac-listesi\" rel=\"noopener\">TEB\u2019in 2 Ekim 2026 tarihli \u00fcr\u00fcn listesinde<\/a> bu etken maddeyi i\u00e7eren \u00fcr\u00fcn kay\u0131tlar\u0131 do\u011fruland\u0131: APO-FLECAINIDE TAB 50 MG 100 BTL; FLECAINIDE 100 MG TABLETS (NORMON); FLECAINIDE ACETAT 100 MG 60 TABLETS-AUROBINDO ve di\u011fer kay\u0131tl\u0131 \u00fcr\u00fcnler. <a href=\"https:\/\/www.titck.gov.tr\/dinamikmodul\/126\" rel=\"noopener\">T\u0130TCK\u2019nin 28 Eyl\u00fcl 2026 tarihli etken madde listesi<\/a> ayr\u0131ca kontrol edildi. Temin ko\u015fullar\u0131 hastaya, re\u00e7eteye, endikasyona ve gerekli onaylara g\u00f6re de\u011fi\u015febilir; listede yer almak g\u00fcncel stok veya geri \u00f6deme garantisi de\u011fildir. Klinik kullan\u0131m alan\u0131 a\u015fa\u011f\u0131daki \u00fcr\u00fcn belgesine g\u00f6re a\u00e7\u0131klan\u0131r; temin listesindeki tan\u0131 ko\u015fullar\u0131 tek ba\u015f\u0131na yeni bir klinik endikasyon olu\u015fturmaz.<\/p>\n<h2>Kaynaklar<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/11891\/smpc\" rel=\"noopener\">Tillomed Flecainide UK SmPC; metin revizyonu 02.10.2026<\/a> (Tillomed Flecainide UK SmPC; metin revizyonu 02.10.2026)<\/li>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/3086\/smpc\" rel=\"noopener\">Milpharm Flecainide UK SmPC; metin revizyonu 12.06.2026<\/a> (Milpharm Flecainide UK SmPC; metin revizyonu 12.06.2026)<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18754843\/\" rel=\"noopener\">Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects<\/a> \u2014 Lim KS; Cho JY; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Shin SG; Yu KS; British Journal of Clinical Pharmacology; 2008; DOI: 10.1111\/j.1365-2125.2008.03267.x<\/li>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/13145\/smpc\" rel=\"noopener\">Pfizer PAXLOVID Birle\u015fik Krall\u0131k SmPC; 28.10.2026 tarihinde kontrol edilen belge<\/a> (Pfizer PAXLOVID Birle\u015fik Krall\u0131k SmPC; 28.10.2026 tarihinde kontrol edilen belge)<\/li>\n<\/ul>\n<p>Kaynak kontrol\u00fc: <time datetime=\"2026-10-28\">28 Ekim 2026<\/time>. Bu tarih, bir hekim veya eczac\u0131 taraf\u0131ndan klinik inceleme yap\u0131ld\u0131\u011f\u0131 anlam\u0131na gelmez. Ki\u015fisel tedavi plan\u0131 i\u00e7in kullan\u0131lan \u00fcr\u00fcn\u00fcn g\u00fcncel talimat\u0131 ve sa\u011fl\u0131k uzman\u0131n\u0131n de\u011ferlendirmesi esas al\u0131n\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Flecainide (Flekainid), Flekainid etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi  [&#8230;]<\/p>\n","protected":false},"featured_media":0,"template":"","ism_etken_madde":[1278],"class_list":["post-11655","ism_drug","type-ism_drug","status-publish","hentry","ism_etken_madde-flekainid"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/ism_drug"}],"version-history":[{"count":1,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11655\/revisions"}],"predecessor-version":[{"id":11656,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11655\/revisions\/11656"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11655"}],"wp:term":[{"taxonomy":"ism_etken_madde","embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fism_etken_madde&post=11655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}